INTRODUCTION
============

The gold standard has been to put the left internal mammary artery (LIMA) to the left anterior descending artery (LAD) in coronary artery bypass grafting because of its excellent long-term patency rate proved by many studies.^[@ref1]-[@ref3])^ On the other hand, in patients with severe left ventricular dysfunction (SLVD) whose ejection fraction (EF) is less than 35%, the beneficial role of LIMA to LAD has not yet been clearly demonstrated. Some investigators have evaluated the results of CABG in patients with SLVD, and they indicate that angina class, coronary heart failure class, quality of life, and ventricular function do improve after CABG in patients with SLVD, but they also report a very high short-term mortality risk, as well as rather poor longer-term survival after CABG.^[@ref4]-[@ref6])^

In the present study, we aim to study the mid-term outcome of SLVD patients undergoing CABG and roles of intraoperative characteristics of bypass conduits measured by transit time flow meter on improvement of EF and survival.

PATIENTS AND METHODS
====================

From April 2000 to November 2008, we identified 20 patients with SLVD (EF \<0.35) who were operated upon by a single surgeon (MHS) for isolated CABG. The data on these patients were retrospectively reviewed for the purpose of this study.

All patients had SLVD confirmed by echocardiography, cardiac catheterization, or nuclear scintigraphy at the time of operation before being included in this study. Improvement in EF was assessed by echocardiography twelve months after the surgery performed at our institution.

All the grafts of all the patients were verified for satisfactory patency by intraoperative transit time flow meter measurement (Medistim, Oslo, Norway) by applying our cut-off values already reported.^[@ref7],[@ref8])^

The survival curve was plotted using a Kaplan-Meier analysis to obtain actuarial survival using the StatView software package (Abacus Concepts, Cary, NC). The Student's *t*-test for paired data was used to analyze the significance or differences between preoperative and postoperative EF and left ventricular dimensions. The sixth degree nomial distribution was used to show coefficiency.

Approval of this retrospective study was obtained from the Ethics Committee of the Gifu Prefectural Tajimi Hospital. The Committee waived individual consent for the study.

RESULTS
=======

Patients
--------

From April 2000 to November 2008, 20 patients with SLVD (mean EF 0.31±0.04) underwent isolated CABG. Twelve were men and eight were women ranging from 66 to 77 years old. Operative profile was shown in [Table 1](#table1){ref-type="table"}.

###### 

Operative Profile

  ---------------------- ------
  Arrested ONCAB         6
  Beating ONCAB          11
  OPCAB                  3
  Average graft number   2.70
  LIMA                   20
  RA                     14
  SVG                    20
  ---------------------- ------

ONCAB: On Pump Coronary Artery Bypass; OPCAB: Off Pump Coronary Artery Bypass; LIMA: Left Internal Mammary Artery; RA: Radial Artery; SVG: Saphenous Vein Graft

Mortality and morbidity
-----------------------

[Table 2](#table2){ref-type="table"} showed the postoperative mortality and morbidity. There was one death, which was due to low output syndrome three weeks after operation. One patient had ventricular dysrhythmia which was treated by amiodarone. Four patients needed prolonged mechanical ventilation of more than 72 hours. Two patients needed temporary hemodialysis.

###### 

Mortality and Morbidity

  -------------------------- -----------
  Operative Mortality        1 (5.00%)
  Cardiac Complications      1 (5.00%)
  Neuro Complications        0 (0%)
  Pulmonary Complications    4 (20.0%)
  Infectious Complications   0 (0%)
  Renal Complications        2 (10.0%)
  Bleeding Complications     0 (0%)
  -------------------------- -----------

Mid-term survival
-----------------

[Figure 1](#fig01){ref-type="fig"} showed a rough survival curve. 75% actuarial survival was obtained at 5 years.
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EF and left ventricular dimension improvements
----------------------------------------------

[Figure 2](#fig02){ref-type="fig"} showed EF improvements. EF increased to 10.7±10.2% postoperatively. Left ventricular end-systolic volume index (LVESVI) decreased to 21.5±10.6 postoperatively. Left ventricular end-diastolic volume index (LVEDVI) decreased to 26.3±10.2 postoperatively. Tei index^[@ref9])^ decreases to 0.11±0.32 postoperatively. All the cardiac parameters improved significantly (*p* \< 0.01).
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EF improvement and grafts flow characteristics
----------------------------------------------

[Figure 3](#fig03){ref-type="fig"} to 6 showed relationships between EF improvement and grafts flow characteristics. The strongest coefficient was observed between EF improvements and LIMA to LAD flow and its pulsatile index (PI) (R^2^=0.737 and 0.639, respectively). The others were statistically insignificant. In [Figure 3](#fig03){ref-type="fig"}, it was inferred that if LIMA flow was more than 30 ml/min, anticipated improvement of EF would be more than 15%. In [Figure 4](#fig04){ref-type="fig"}, it was shown that if LIMA PI was less than 1.5, anticipated improvement of EF would be more than 15%.
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DISCUSSION
==========

Patients with SLVD have been a challenging cohort for cardiac surgeons because of its poor operative mortality and dismal survival rate. Despite improvements of several medical and biological modalities such as cardiac resynchronization therapy^[@ref10])^ and cell-based myocardial regeneration therapies,^[@ref11],[@ref12])^ very sick patients are often ultimately referred for surgical myocardial revascularization or ventricular remodeling surgery by cardiologists.

Despite the ominous outlook of operative mortality and long-term survival, recent improvements of both medical optimization and surgical techniques have made it possible to attain reasonable postoperative mortality and good survival rate. Literature published since 2001 showed 4.4% to 11% mortality and 59% to 77% survival rate at 5 years in these SLVD patients who underwent CABG alone.^[@ref5],[@ref6],[@ref13],[@ref14])^ The results of this study, i.e, 5.0% mortality and 75% survival at 5 years, were in accordance with them.

In this study we focused on the roles of graft conduits in improving EF because such studies were few. Luciani et al concluded that use of the left internal thoracic artery was inversely associated with return of congestive heart failure with an odds ratio 0.84 and *p* value \< 0.03 \[15\]. We found that only LIMA flow and PI had the statistically strongest coefficient power on improvement of EF with R^2^ of 0.737 and 0.639, respectively. Since we reported that mean LIMA flow of 15 ml/min and PI of 5.1 were the good cutoff criteria for a functioning graft,^[@ref7],[@ref8])^ this study showed that mean LIMA flow of 30 ml/min and PI of 1.5 were good predictors for improvement of EF. As shown in [Figure 3](#fig03){ref-type="fig"} and [4](#fig04){ref-type="fig"}, EF improvement was not linear to flow and PI. This was thought to be due to different LAD region, LAD viability, and coronary flow reserve.

Limitations included that a sample size of 20 patients was too small sample size to draw significant conclusions and this study was retrospective. On the other hand, even with a sample size of 20 patients, the polynomial coefficient curve could be constructed with statistically meaningful significance, and that this study was not biased.

In conclusion, we reappraised the mid-term beneficial effects of the internal mammary artery anastomosed to the left anterior descending artery in patients with severe left ventricular function.
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